Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AnGes, Inc.
Minute Insight: GE Healthcare Partners With MediView XR To Create AR Solution For Integrated MR Imaging
GE Healthcare and MediView announced a partnership to co-develop a technology platform that integrates medical imaging into mixed reality solutions.
Genfit CEO Pascal Prigent talks to Scrip about the company's high-profile trial failure in NASH and the pipeline pivot to various other drug candidates for rare liver diseases.
During Q3, biopharma merger and acquisition value reached $15.4bn and drew in $37.6bn in potential deal value from alliances. Device company M&A values reached $550m, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $1.9bn.
Activ Surgical’s Platform Technology Strives To Be The ‘Waze’ Intra-Operative Navigation System For Surgeons
Activ Surgical’s CEO Todd Usen sat down with Medtech Insight to discuss the company’s product portfolio – ActivSight, an imaging module technology and ActivInsights, which uses artificial intelligence and machine learning to produce further clinical insights based on surgical data.
- Gene Therapy, Cell Therapy
- Large Molecule
- Other Names / Subsidiaries
- AnGes Co., Ltd.
- AnGes MG
- EmendoBio Inc.
- Emendo Biotherapeutics